diphenyl α-N-(benzyloxycarbonyl)amino-2-methylpropylphosphonate

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: diphenyl α-N-(benzyloxycarbonyl)amino-2-methylpropylphosphonate
• 英文别名: diphenyl benzyloxycarbonylaminoisopropylmethanephosphonate；Diphenyl 1-(cbz-amino)isobutylphosphonate；benzyl N-(1-diphenoxyphosphoryl-2-methylpropyl)carbamate
• 化学式: C₂₄H₂₆NO₅P
• 分子量: 439.448
• InChiKey: IBIWSUMXYFEOAT-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.8
• 重原子数：
  31
• 可旋转键数：
  10
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.21
• 拓扑面积：
  73.9
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  diphenyl α-N-(benzyloxycarbonyl)amino-2-methylpropylphosphonate 在 氢溴酸 、 三乙胺 作用下， 以 二氯甲烷 、 水 、 溶剂黄146 为溶剂， 反应 0.5h， 生成 1-formamido-2-methylpropanephosphonic acid diphenyl ester
  参考文献：
  名称：

  Synthesis of isocyanide derivatives of α-aminoalkylphosphonate diphenyl esters

  摘要：

  This letter describes the first example of the synthesis of isocyanide derivatives of alpha-aminoalkylphosphonate diphenyl esters. This method produces the title compounds in high purity and in very good yields. It also permits the generation of an alpha-aminophosphonate-based library of biologically active phosphonopeptides. Preliminary experiments demonstrate their application as substrates for the Ugi-type multicomponent condensation. (c) 2006 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tetlet.2006.04.058
• 作为产物：
  描述：

  苯酚 在 溶剂黄146 、 三氯化磷 作用下， 以 乙腈 为溶剂， 反应 8.0h， 生成 diphenyl α-N-(benzyloxycarbonyl)amino-2-methylpropylphosphonate
  参考文献：
  名称：

  Human Neutrophil Elastase Phosphonic Inhibitors with Improved Potency of Action

  摘要：

  Herein, we present the synthesis and the measurement of the inhibitory activity of novel peptidyl derivatives of alpha-aminoalkylphosphonate diaryl esters as human neutrophil elastase inhibitors. Their selectivity against other serine proteases, including porcine pancreatic elastase, chymotrypsin, and trypsin, was also demonstrated. We also describe the preparation of single peptide diastereomers. The most active and selective compound developed possessed a k(inact)/K-1 of 2353000 M-1 s(-1), which is the most potent irreversible peptidyl inhibitor of human neutrophil elastase reported to date. The peptidyl inhibitors were demonstrated to be stable in PBS buffer and human plasma, as were their complexes with HNE.

  DOI：

  10.1021/jm300599x

文献信息

• Synthesis and bioactivities of 1,3,2-benzodiazaphosphorin-2-carboxamide 2-oxides containing?-aminophosphonate groups
  作者：Junmin Huang、Ruyu Chen

  DOI：10.1002/hc.6

  日期：——

  antitumor and antiviral agents with high activity and low toxicity, a series of 1-ethoxycarbonylmethyl-3-ethyl-1,2,3,4-tetrahydro-4-oxo-1,3,2-benzodiazaphosphorin-2-carboxamide 2-oxides containing α-aminophosphonate groups have been designed and synthesized by a convenient one-pot procedure in good yields. The structures of products were confirmed by 1H NMR, 31P NMR, IR spectra, and elemental analyses

  为了寻找新的高活性、低毒的抗肿瘤和抗病毒药物，一系列1-ethoxycarbonylmethyl-3-ethyl-1,2,3,4-tetrahydro-4-oxo-1,3,2-benzodiazaphosphorin-含有 α-氨基膦酸酯基团的 2-甲酰胺 2-氧化物已通过方便的一锅法以良好的产率设计和合成。产物的结构经1H NMR、31P NMR、IR光谱和元素分析确证。生物测定结果表明，与对比药物2,4-二氧六氢-1,3,5-三嗪相比，其中一些具有优异的抗烟草花叶病毒活性并表现出更高的抑制作用。© 2001 John Wiley & Sons, Inc. 杂原子化学 12:97–101, 2001
• Structure-activity analysis of peptidic Chlamydia HtrA inhibitors
  作者：Ayodeji A. Agbowuro、Jimin Hwang、Emma Peel、Rami Mazraani、Alexandra Springwald、James W. Marsh、Laura McCaughey、Allan B. Gamble、Wilhelmina M. Huston、Joel D.A. Tyndall

  DOI：10.1016/j.bmc.2019.07.049

  日期：2019.9

  Chlamydia trachomatis high temperature requirement A (CtHtrA) is a serine protease that performs proteolytic and chaperone functions in pathogenic Chlamydiae; and is seen as a prospective drug target. This study details the strategies employed in optimizing the irreversible CtHtrA inhibitor JO146 [Boc-Val-Pro-ValP(OPh)2] for potency and selectivity. A series of adaptations both at the warhead and specificity

  沙眼衣原体高温需要A（CtHtrA）是一种丝氨酸蛋白酶，在致病性衣原体中具有蛋白水解和伴侣功能。并被视为潜在的药物目标。这项研究详细介绍了针对效力和选择性优化不可逆CtHtrA抑制剂JO146 [Boc-Val-Pro-Val P（OPh）2 ]的策略。弹头和特异性残基P 1和P 3的一系列适应作用产生了23种类似物，已在人嗜中性弹性蛋白酶（HNE）和CtHtrA酶检测以及衣原体检测中进行了测试。细胞培养测定。还进行了胰蛋白酶和胰凝乳蛋白酶抑制试验以测量脱靶选择性。用α-酮基苯并噻唑代替膦酸酯部分可产生可逆的类似物，并具有相当大的CtHtrA抑制作用和细胞培养活性。在P 3（8a）处的叔亮氨酸对CtHtrA的抑制活性提高了约33倍， 对HNE的IC 50 = 0.68±0.02 µM，而在P 1处的缬氨酸保留了最佳的抗衣原体活性。这项研究提供了获得临床相关抑制剂的途径。
• Structure-based design, synthesis, and evaluation of the biological activity of novel phosphoroorganic small molecule IAP antagonists
  作者：Agnieszka Łupicka-Słowik、Mateusz Psurski、Renata Grzywa、Monika Cuprych、Jarosław Ciekot、Waldemar Goldeman、Elżbieta Wojaczyńska、Jacek Wojaczyński、Józef Oleksyszyn、Marcin Sieńczyk

  DOI：10.1007/s10637-020-00923-4

  日期：2020.10

  caspases (Smac) that share an IAP binding motif (IBM). The main purpose of the present study was the design and synthesis of phosphorus-based peptidyl antagonists of IAPs that mimic the endogenous Smac protein, which blocks the interaction between IAPs and caspases. Based on the structure of the IAP antagonist and recently reported thiadiazole derivatives, we designed and evaluated the biochemical properties

  新型抗癌疗法采用的策略之一是通过阻断细胞凋亡蛋白抑制剂 (IAP) 和半胱天冬酶之间的相互作用，使细胞凋亡过程回到正轨。半胱天冬酶的活性受半胱天冬酶/半胱天冬酶原蛋白水解级联中的半胱天冬酶本身以及它们与 IAP 的相互作用调节。半胱天冬酶可以从 IAP 的抑制影响中释放出来，这些蛋白质是共享一个 IAP 结合基序 (IBM) 的促凋亡蛋白，例如半胱天冬酶的次级线粒体激活剂 (Smac)。本研究的主要目的是设计和合成 IAP 的磷基肽基拮抗剂，模拟内源性 Smac 蛋白，阻断 IAP 和半胱天冬酶之间的相互作用。基于 IAP 拮抗剂的结构和最近报道的噻二唑衍生物，N -Me-Ala-Val/Chg-Pro-OH 基序（Chg：环己基甘氨酸）。获得的化合物与凋亡蛋白重复序列​​杆状病毒抑制剂 X-连锁抑制剂（XIAP BIR3）结构域的结合沟相互作用的能力通过荧光偏振测定进行检查，同时它们诱导自身泛素化随后蛋白酶体降解的潜力使用
• Stereochemical basis for the anti-chlamydial activity of the phosphonate protease inhibitor JO146
  作者：Ayodeji A. Agbowuro、Rami Mazraani、Laura C. McCaughey、Wilhelmina M. Huston、Allan B. Gamble、Joel D.A. Tyndall

  DOI：10.1016/j.tet.2017.10.031

  日期：2018.3

  S,S-Boc-Val-Pro-ValP(OPh)2] and greater than 100 – fold increase in cellular anti-chlamydial activity compared to JO146-D1 which possesses the unnatural valine at P1. JO146 and the individual diastereomers had excellent selectivity for the serine protease HNE over the potential off-target serine proteases trypsin and chymotrypsin. Docking studies supported the biological data with a geometrically unfavoured

  JO146是衣原体HtrA（CtHtrA）的肽膦酸酯抑制剂的两种非对映异构体的混合物，据报道对人和考拉均具有抗衣原体物种的活性。在这项研究中，我们分离了单独的非对映异构体JO146-D1和JO146-D2（纯度≥90％），并评估了它们对丝氨酸蛋白酶人类嗜中性弹性蛋白酶（HNE）的抑制活性，该酶在结构和功能上与CtHtrA以及在沙眼衣原体细胞培养中。JO146-D2 [ S，S，R -Boc-Val-Pro-Val P（OPh）2 ]是在P1处具有生理相关缬氨酸的异构体，在体外具有约2.5倍的增加HNE抑制效力超过JO146-D1 [ S，S，S -Boc-Val-Pro-Val P（OPh）2 ]，与具有非天然缬氨酸的JO146-D1相比，细胞抗衣原体活性提高了100倍以上在P1。JO146和单个非对映异构体对丝氨酸蛋白酶HNE的选择性优于潜在的脱靶丝氨酸蛋白酶胰蛋白酶和胰凝乳蛋白酶。对接
• New aromatic monoesters of α-aminoaralkylphosphonic acids as inhibitors of aminopeptidase N/CD13
  作者：Renata Grzywa、Anna M. Sokol、Marcin Sieńczyk、Magdalena Radziszewicz、Beata Kościołek、Michael P. Carty、Józef Oleksyszyn

  DOI：10.1016/j.bmc.2010.02.056

  日期：2010.4

  A series of new aromatic monoesters of α-aminoaralkylphosphonic acids were synthesized by selective hydrolysis of corresponding aromatic diesters of α-aminoaralkylphosphonic acids. New potential inhibitors of aminopeptidase N/CD13, an enzyme important in tumour angiogenesis, were developed. Some derivatives of the homophenylalanine and norleucine related monoaryl phosphonates displayed higher inhibition

  通过选择性水解相应的α-氨基芳烷基膦酸芳族二酯，合成了一系列新的α-氨基芳烷基膦酸芳族单酯。开发了新的潜在的氨基肽酶N / CD13抑制剂，这是一种在肿瘤血管生成中很重要的酶。高苯丙氨酸和正亮氨酸相关的单芳基膦酸酯的一些衍生物显示出比相应的α-氨基芳烷基膦酸对氨基肽酶N / CD13更高的抑制能力。单独或与TNF-α一起检测了一种新抑制剂对人PANC-1和HT-1080细胞系生长的影响。